The outer limiting membrane (OLM) revisited: clinical implications.
OBJECTIVE
The outer limiting membrane (OLM) is considered to play a role in maintaining the structure of the retina through mechanical strength. However, the observation of junction proteins located at the OLM and its barrier permeability properties may suggest that the OLM may be part of the retinal barrier.


METHODS
Normal and diabetic rat, monkey, and human retinas were used to analyze junction proteins at the OLM. Proteome analyses were performed using immunohistochemistry on sections and flat-mounted retinas and western blotting on protein extracts obtained from laser microdissection of the photoreceptor layers. Semi-thin and ultrastructure analyses were also reported.


RESULTS
In the rat retina, in the subapical region zonula occludens-1 (ZO-1), junction adhesion molecule (JAM), an atypical protein kinase C, is present and the OLM shows dense labeling of occludin, JAM, and ZO-1. The presence of occludin has been confirmed using western blot analysis of the microdissected OLM region. In diabetic rats, occludin expression is decreased and glial cells junctions are dissociated. In the monkey retina, occludin, JAM, and ZO-1 are also found in the OLM. Junction proteins have a specific distribution around cone photoreceptors and Müller glia. Ultrastructural analyses suggest that structures like tight junctions may exist between retinal glial Müller cells and photoreceptors.


CONCLUSIONS
In the OLM, heterotypic junctions contain proteins from both adherent and tight junctions. Their structure suggests that tight junctions may exist in the OLM. Occludin is present in the OLM of the rat and monkey retina and it is decreased in diabetes. The OLM should be considered as part of the retinal barrier that can be disrupted in pathological conditions contributing to fluid accumulation in the macula.
Omri
S
S
INSERM, U872 Physiopathology of ocular diseases: Therapeutic innovations, Paris, France.
Omri
B
B
Savoldelli
M
M
Jonet
L
L
Thillaye-Goldenberg
B
B
Thuret
G
G
Gain
P
P
Jeanny
J C
JC
Crisanti
P
P
Behar-Cohen
Francine
F
J Cell Sci. 2008 Jul 1;121(Pt 13):2115-22
18565824
Nat Rev Mol Cell Biol. 2001 Apr;2(4):285-93
11283726
Nature. 2008 Mar 27;452(7186):478-82
18368118
Exp Eye Res. 2008 Apr;86(4):601-11
18294631
J Neurosci Methods. 2004 Sep 30;138(1-2):141-8
15325122
Nippon Ganka Gakkai Zasshi. 1976 Aug 10;80(8):598-607
988728
Exp Cell Res. 1999 Aug 1;250(2):452-64
10413599
Invest Ophthalmol Vis Sci. 2007 Sep;48(9):3928-36
17724169
J Comp Neurol. 2007 Nov 10;505(2):166-76
17853450
J Comp Neurol. 1990 May 1;295(1):155-64
2341633
Ann N Y Acad Sci. 2009 May;1165:220-7
19538310
Invest Ophthalmol Vis Sci. 2009 Mar;50(3):1454-63
19060272
Dev Biol. 2005 Dec 1;288(1):234-47
16271712
Exp Eye Res. 2004 Dec;79(6):769-77
15642314
J Cell Biol. 1999 Nov 15;147(4):891-903
10562289
J Neurosci. 2009 May 13;29(19):6266-75
19439604
Int Rev Cytol. 2007;258:195-234
17338922
J Cell Sci. 2006 Dec 1;119(Pt 23):4819-27
17130295
Invest Ophthalmol Vis Sci. 1994 Oct;35(11):3792-8
7928176
Invest Ophthalmol Vis Sci. 1985 Oct;26(10):1377-80
4044165
Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1298-305
7775107
J Cell Biol. 1963 May;17:375-412
13944428
Biochim Biophys Acta. 2008 Mar;1778(3):660-9
17854762
Ann N Y Acad Sci. 2009 May;1165:62-8
19538289
Exp Eye Res. 1985 May;40(5):687-96
2408910